1.045USD-0.95%Mkt Cap: 43.91M USDP/E: —Last update: 2026-06-01
MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.…
Industry Peers
Drug Manufacturers - GeneralIndicators:|
Key Statistics
Company
Market Cap43.91M USD
Enterprise Value35.14M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-10.44M USD
Revenue/Share—
Last Price1.045 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees—
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.59
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B4.77
EPS (TTM)-1.27
EPS (Forward)-0.41
52W Range
0.90009% of range2.450
52W High2.450 USD
52W Low0.9000 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-100.49%
ROA-94.13%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.66M USD
CapEx (TTM)—
FCF Margin—
FCF Yield0.77%
Net Debt-9.41M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio82.16
Quick Ratio81.97
Book Value/Sh0.2220 USD
Cash/Share0.2240 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.42.02M
Float35.03M
Insiders16.71%
Institutions5.03%
Short Interest
Short Ratio2.9d
Short % Float1.05%
Short % Out.0.97%
Shares Short408.16K
Short (prev mo.)378.49K
Technical
SMA 501.033 (+1.2%)
SMA 2001.303 (-19.8%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)140.79K
Avg Vol (10d)167.67K
Technical Indicators
RSI (14)53.3
MACD0.0005
MACD Signal-0.0140
MACD Hist.+0.0145
BB Upper1.101 USD
BB Middle1.006 USD
BB Lower0.9096 USD
BB Width19.07%
ATR (14)0.0646 USD
Vol Ratio (20d)0.50x